BlueLinx Holdings Inc. — Form 10-Q Summary
Period clarification: The request metadata says 2019 Q3, but the filing is for the quarter ended September 26, 2020. The comparable prior-year quarter ended September 28, 2019.
Business context and reporting period
BlueLinx distributes specialty and structural building products through a U.S. network of distribution centers. The filing reports fiscal 2020’s third quarter and first nine months; fiscal 2020 is a 53-week year ending January 2, 2021. The company said quarterly results are seasonal and may not indicate full-year results.
Key financial metrics
| Metric | Q3 2020 | Q3 2019 | Nine months 2020 | Nine months 2019 |
|---|---|---|---|---|
| Net sales | $871.1 million | $678.7 million | $2,231.9 million | $2,023.8 million |
| Gross profit / margin | $159.5 million / 18.3% | $93.7 million / 13.8% | $353.5 million / 15.8% | $273.9 million / 13.5% |
| Operating income | $81.5 million | $6.3 million | $111.9 million | $32.9 million |
| Net income (loss) | $55.1 million | $(7.0) million | $61.0 million | $(7.5) million |
| Diluted EPS | $5.72 | $(0.75) | $6.48 | $(0.80) |
- Cash flow: Nine-month operating cash flow was $74.4 million, versus cash used of $37.6 million in 2019. Investing activities provided $8.8 million; financing activities used $84.7 million. Cash was $10.2 million at quarter-end.
- Liquidity: Revolver borrowings were $263.0 million, with $202.1 million of excess availability. The $600 million asset-based facility matures October 2022. The company reported compliance with its revolver and term-loan covenants at quarter-end.
- Debt and leases: Revolver and term-loan principal totaled approximately $320.8 million; finance lease obligations were $273.2 million. The term loan balance was $57.8 million at quarter-end, with an 8.0% weighted-average rate. On October 2, 2020, it was reduced to $44.4 million, after which the company said the term-loan leverage covenant would not apply beginning in Q4.
- Balance sheet: Total assets were $1,023.2 million and total liabilities $985.0 million; stockholders’ equity was $38.2 million, compared with a deficit of $26.1 million at December 28, 2019. Receivables were $308.6 million and inventory $306.0 million.
Material changes and notable items
- Q3 sales rose 28.3%; management attributed the increase chiefly to wood-based commodity price inflation. Structural-product sales increased to $375.1 million from $225.7 million, while specialty-product sales rose to $496.0 million from $453.0 million.
- Management said lumber and panel index prices more than doubled year over year in Q3, supporting revenue and margins. Supply outages slightly reduced structural-product volume late in the quarter.
- For the first nine months, sales increased 10.3%, supported by commodity inflation and higher volume, partly offset by $50.5 million of sales lost after discontinuation of a siding program.
- Q3 operating income included an $8.7 million gain from the Denver warehouse sale-leaseback. The transaction generated $10.6 million of net proceeds, used to repay the term loan.
- Nine-month results included a $3.9 million discrete tax benefit related to the CARES Act and interest-deduction rules. Management said acquisition-related costs declined to $1.8 million from $11.3 million in the comparable period.
- Sale-leaseback proceeds and debt repayments reduced term-loan principal substantially, while finance lease obligations increased. Nine-month cash from operations also benefited from improved working capital compared with 2019.
Outlook, risks and contingencies
- Management expected lumber and panel prices to trend downward from late-Q3 peaks as supply constraints eased; it cautioned that price reversals could reduce revenue and margins. Single-family housing starts had rebounded, but the pandemic’s future effects remained uncertain.
- The company said ordinary-course sales and revolver availability were expected to fund routine needs for at least 12 months, assuming operations were not significantly affected by a prolonged pandemic impact. No specific earnings or revenue guidance was provided.
- COVID-19 risks include renewed business restrictions, weaker customer demand or credit quality, supply-chain disruption, and productivity impacts. The company described cost control and liquidity as continuing priorities.
- The NYSE had notified the company of a listing-standard deficiency in April 2020 because market capitalization and stockholders’ equity were each below $50 million. The exchange accepted a plan with a cure period through January 1, 2022; the company said its 30-trading-day average market capitalization was $184.1 million at September 26, 2020. Delisting remained a risk if compliance was not regained or maintained.
- Management reported routine legal and environmental matters, with reserves established for probable losses and no expected material adverse effect on consolidated financial condition, results, or cash flows. Two collective bargaining agreements remained expected to be renegotiated by year-end.
- On October 26, 2020, performance targets for certain 2018 restricted stock unit awards were reduced by 10%, from $150 million to $135 million of trailing 12-month Adjusted EBITDA.
Important facts for investors to verify
- Confirm the filing period: this is Q3 2020, not Q3 2019.
- Assess how much of Q3’s unusually strong revenue and margin performance depended on commodity-price inflation, and the effect of anticipated price declines.
- Monitor housing demand, supply availability, pandemic developments, receivables and working-capital needs, and the company’s liquidity.
- Track term-loan repayments, finance lease obligations, covenant status, and the use of real-estate sale-leaseback proceeds.
- Check continuing NYSE listing compliance and progress under the accepted remediation plan.
- Consider the Denver sale-leaseback gain, discrete tax benefit, and amended equity-award performance targets when evaluating recurring earnings and incentives.